| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |